Search Results

You are looking at 271 - 280 of 542 items for :

  • "pathology" x
  • Refine by Access: All x
Clear All
Full access

improved efficiency and confidence for investigators. Clinical Oncology AB2016-7. Effect of Oncotype DX Recurrence Score and Recurrence Score-Pathology-Clinical Score on Management Decisions in Early-Stage Breast Cancer Jincy Clement, MD a

Full access

William J. Gradishar, Benjamin O. Anderson, Sarah L. Blair, Harold J. Burstein, Amy Cyr, Anthony D. Elias, William B. Farrar, Andres Forero, Sharon Hermes Giordano, Lori J. Goldstein, Daniel F. Hayes, Clifford A. Hudis, Steven J. Isakoff, Britt-Marie E. Ljung, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Robert S. Miller, Mark Pegram, Lori J. Pierce, Elizabeth C. Reed, Kilian E. Salerno, Lee S. Schwartzberg, Mary Lou Smith, Hatem Soliman, George Somlo, John H. Ward, Antonio C. Wolff, Richard Zellars, Dorothy A. Shead, and Rashmi Kumar

Pathology Assessment A central component of breast cancer treatment is full knowledge of disease extent and biologic features. These factors contribute to the determination of disease stage, assist in estimating the risk of cancer recurrence, and provide

Full access

Ali Bazarbachi, Hamdy A. Azim, Hussain Alizadeh, Mahmoud Aljurf, Ibrahim Barista, Naeem A. Chaudhri, Zahira Fahed, Omar A. Fahmy, Ardeshir Ghavamzadeh, Mohamed H. Khalaf, Sami Khatib, Aghiad Kutoubi, Semra Paydas, Hanadi Rafii Elayoubi, Ghazi Zaatari, Hamdy M. Zawam, and Andrew D. Zelenetz

experts from multiple specialties, including hematology, medical oncology, radiation oncology, pathology, and diagnostic radiology, join the NCCN–MENA guideline committee. These individuals were contacted by e-mail and agreed to participate. All members

Full access

Andrea Maurichi, Rosalba Miceli, Roberto Patuzzo, Francesco Barretta, Gianfranco Gallino, Ilaria Mattavelli, Consuelo Barbieri, Andrea Leva, Umberto Cortinovis, Elena Tolomio, Milena Sant, Gianpiero Castelli, Leonardo Zichichi, Giovanni Pellacani, Ignazio Stanganelli, Marco Simonacci, Ausilia Manganoni, Corrado Del Forno, Gioachino Caresana, Catherine Harwood, Daniele Bergamaschi, Konstantinos Lasithiotakis, Dorothy Bennett, Vittoria Espeli, Cristina Mangas, Sandra Leoni Parvex, Barbara Valeri, Mara Cossa, Marta Barisella, Alessandro Pellegrinelli, Claudia Miranda, Andrea Anichini, Roberta Mortarini, Odysseas Zoras, and Mario Santinami

. Pathology of Melanocytic Nevi and Malignant Melanoma . 2nd ed . New York, NY : Springer ; 2004 : 238 – 356 . 10.1007/978-0-387-21619-5_10 11. Elder DE , Xu X . The approach to the patient with a difficult melanocytic lesion . Pathology 2004 ; 36

Full access

David J. Worhunsky, Yifei Ma, Yulia Zak, George A. Poultsides, Jeffrey A. Norton, Kim F. Rhoads, and Brendan C. Visser

are more likely to have staging based on pathology specimens, whereas SS patients are more often staged clinically (ie, via imaging) without pathologic data. This is supported by the difference in the rate of surgery between the groups, with patients

Full access

Patricia Ellen Goldhoff, Poonam Vohra, Kanti Pallav Kolli, and Britt-Marie Ljung

pathology databases of 2 hospitals, UCSF Medical Center (UCSFMC) and Zuckerberg San Francisco General Hospital (ZSFGH), were queried for all CT- or ultrasound-guided liver FNABs and CNBs performed from 1997 through 2016. Only concurrent CNBs and FNAB

Full access

Brigette A. Davis, Jenerius A. Aminawung, Maysa M. Abu-Khalaf, Suzanne B. Evans, Kevin Su, Rajni Mehta, Shi-Yi Wang, and Cary P. Gross

aspects of population-based cancer epidemiology studies. All hospitals and private pathology laboratories in Connecticut are required by law to report cancer cases to the CTR. We used CTR data located in the Connecticut Department of Public Health on

Full access

Thanh H. Dellinger, Amy A. Hakim, Stephen J. Lee, Mark T. Wakabayashi, Robert J. Morgan, and Ernest S. Han

Vulva with stage IA vulvar cancer with stromal invasion of ≤1 mm, treatment consists of a wide local excision without further adjuvant treatment for tumors with negative margins on final pathology. For tumors with >1 mm invasion and that are up to

Full access

Jeffrey S. Dome, Elizabeth A. Mullen, David B. Dix, Eric J. Gratias, Peter F. Ehrlich, Najat C. Daw, James I. Geller, Murali Chintagumpala, Geetika Khanna, John A. Kalapurakal, Lindsay A. Renfro, Elizabeth J. Perlman, Paul E. Grundy, and Conrad V. Fernandez

therapeutic trials, and to build a well-annotated tumor bank to enable basic and translational research. Submission of imaging studies, pathology slides, operative notes, and pathology reports was required within 14 days of initial surgical procedure for

Full access

Oxana Palesh, Arianna Aldridge-Gerry, Ayhan Ulusakarya, Elisabet Ortiz-Tudela, Lucile Capuron, and Pasquale F. Innominato

-wake systems results in a higher incidence of pathologies, such as accelerated aging, 8 metabolic syndrome, 9 and affective and cognitive impairments, 10 and also a higher incidence of cancer. 11 Immunity, Metabolic Regulation, and Sleep Strong